Cell Therapy Market Growth, Size, Share, Forecast 2024-2032

IMARC Group, a leading market research company, has recently releases report titled “Cell Therapy Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2032” offers a comprehensive analysis of the industry, which comprises insights on the cell therapy market share. The global market size reached US$ 13.5 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 50.5 Billion by 2032, exhibiting a growth rate (CAGR) of 15.28% during 2024-2032.

Request For Sample Copy of Report: https://www.imarcgroup.com/cell-therapy-market/requestsample

Factors Affecting the Growth of the Cell Therapy Industry:

 

• Increasing Prevalence of Chronic Diseases:

The rising prevalence of chronic diseases, such as cancer, diabetes, cardiovascular disorders, and autoimmune conditions, is propelling the growth of the market. Conventional treatments for many of these diseases often provide limited efficacy. As a result, there is an increase in the demand for innovative and more effective therapies, such as cell therapy. Cell therapy provides a targeted and personalized approach to treating chronic diseases. By harnessing the own cells of patients or using engineered cells, these therapies can address the specific underlying causes of the disease, potentially offering better outcomes compared to traditional treatments.

 

• Advancements in Biotechnology:

Biotechnological innovations are improving the ability to characterize and understand various cell types at a molecular level. This understanding allows for the precise selection and manipulation of cells for therapy, increasing the effectiveness of cell-based treatments. Biotechnology is leading to advanced techniques like CRISPR-Cas9, which enable precise gene editing and cell engineering. This capability allows for the creation of specialized cells with enhanced therapeutic properties, making cell therapies more targeted and potent. Biotechnological advancements are streamlining the process of growing and manufacturing cells for therapy.

 

• Rising Demand for Personalized Medicine:

Personalized medicine can provide treatments that are specifically customized as per individual patients based on their unique genetic, molecular, and clinical profiles. Cell therapy aligns with this approach by offering the potential to create therapies that are precisely matched to the needs of patients. Advancements in genomics and biomarker research are enabling the identification of genetic mutations and biomarkers associated with diseases. Cell therapies can be designed to target these specific genetic factors, making them a key component of personalized treatment strategies.

Leading Companies Operating in the Global Cell Therapy Industry:

 

• AlloSource

 

• Anterogen Co. Ltd.

 

• Cells for Cells

 

• Holostem Terapie Avanzate S.r.l.

 

• JCR Pharmaceuticals

 

• Kolon TissueGene Inc

 

• MEDIPOST

 

• Mesoblast Limited

 

• NuVasive

 

• Stemedica Cell Technologies Inc.

 

• Stempeutics Research Pvt. Ltd

 

• Vericel Corporation

Cell Therapy Market Report Segmentation:

By Cell Type:

 

• Stem Cell

   

  • Bone Marrow

   

  • Blood

   

  • Umbilical Cord-Derived

   

  • Adipose-Derived Stem Cell

   

  • Others

 

• Non-stem Cell

Stem cells represented the largest segment due to their versatility and potential to differentiate into various cell types.

By Therapy Type:

 

• Autologous

 

• Allogeneic

Autologous accounted for the largest market share on account of its reduced risk of immune rejection.

By Therapeutic Area:

 

• Malignancies

 

• Musculoskeletal Disorders

 

• Autoimmune Disorders

 

• Dermatology

 

• Others

Malignancies exhibit a clear dominance in the market as cell therapies, particularly CAR-T cell therapies, are used in treating certain types of cancer.

By End User:

 

• Hospitals and Clinics

 

• Academic and Research Institutes

On the basis of end user, the market has been bifurcated into hospitals and clinics and academic and research institutes.

Regional Insights:

 

• North America (United States, Canada)

 

• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)

 

• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)

 

• Latin America (Brazil, Mexico, Others)

 

• Middle East and Africa

North America enjoys the leading position in the cell therapy market due to a well-established healthcare infrastructure.

Global Cell Therapy Market Trends:

There is a growing number of cell therapy products in various stages of development, reflecting the increasing interest and investment in this field. The increasing demand for immunotherapies, including CAR-T cell therapies and immune checkpoint inhibitors, is strengthening the growth of the market.

Cell therapies are increasingly integrated into personalized medicine approaches, with treatments tailored as per individual patients based on genetic and molecular profiles.

Other Key Points Covered in the Report:

 

• Porters Five Forces Analysis

 

• Value Chain Analysis

 

• Strategic Recommendations

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC Group’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: [email protected]

Tel No:(D) +91 120 433 0800

United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163